Financial

ARCA biopharma Announces C. Jeff Dekker to be Appointed Chief Financial Officer

WESTMINSTER, Colo., May 03, 2021 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today announced C. Jeff Dekker as its Chief Financial Officer, effective May 10, 2021, following Brian Selby’s planned departure after 14 years of […]

New members elected to Occlutech Board of Directors

Medical device company Occlutech Holding AG, one of the world´s leading providers of minimally invasive structural heart disease devices, announces the election of four new members to the board SCHAFFHAUSEN, Switzerland, May 3, 2021 /PRNewswire/ — Occlutech Holding AG (“Occlutech”) today announces that Marianne Dicander Alexandersson, Mette-Marie Harild, Helena Levander, and Michel Lussier have been elected as […]

Sequana Medical Announces New Share Capital Amount and New Number of Shares

Ghent, Belgium, 3 May 2021 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical“), an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant ascites and heart failure, announces in accordance with Article 15 of the Belgian Act of 2 May 2007 on the disclosure of major participations in […]

Zynex Announces 2021 First Quarter Earnings

ENGLEWOOD, Colo., April 29, 2021 /PRNewswire/ — 2021 First Quarter Revenue increased 58% year over year to $24.1 million Orders increased 140% Net loss of $0.7 million; GAAP loss per share $0.02 Adjusted EBITDA loss $0.4 million Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for […]